Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classical cadherins in urological cancers.

L A Giroldi1, T Shimazui, J A Schalken

  • 1University Hospital Nijmegen, The Netherlands.

Morphologie : Bulletin De L'Association Des Anatomistes
|October 26, 2000
PubMed
Summary

Decreased E-cadherin expression is linked to poorer survival in bladder and prostate cancers. Understanding E-cadherin gene transcription could lead to new cancer therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent advances in basic and applied science for the control of taeniasis/cysticercosis in Asia.

The Southeast Asian journal of tropical medicine and public health·2003
Same author

Enhanced insulin gene expression by reduced intracellular glutathione level in insulin secreting cells MIN6.

Diabetes, nutrition & metabolism·2003
Same author

Taenia solium taeniasis/cysticercosis in Papua, Indonesia in 2001: detection of human worm carriers.

Journal of helminthology·2003
Same author

Evaluation of tongue inspection and serology for diagnosis of Taenia solium cysticercosis in swine: usefulness of ELISA using purified glycoproteins and recombinant antigen.

Veterinary parasitology·2003
Same author

Acute effects of ethanol on feeding behavior and leptin-induced STAT3 phosphorylation in rat hypothalamus.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2003
Same author

Dogs as alternative intermediate hosts of Taenia solium in Papua (Irian Jaya), Indonesia confirmed by highly specific ELISA and immunoblot using native and recombinant antigens and mitochondrial DNA analysis.

Journal of helminthology·2002

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Decreased E-cadherin expression, identified via immunohistochemistry, is associated with poor patient survival in bladder and prostate cancers.
  • Cadherin-6 may functionally replace E-cadherin in the proximal kidney tubule and its derived tumors.
  • Impaired E-cadherin function enhances cellular invasiveness through various mechanisms including genetic mutation, altered transcription, or post-translational modifications.

Purpose of the Study:

  • To evaluate the clinical utility of E-cadherin expression as a prognostic marker in a large-scale prospective study.
  • To investigate the regulatory mechanisms of E-cadherin transcription for potential therapeutic interventions.

Main Methods:

  • Immunohistochemistry was used to assess E-cadherin expression.

Related Experiment Videos

  • Analysis of gene transcription, mutation, and post-translational modifications related to E-cadherin function.
  • Evaluation of interactions between E-cadherin and cytoskeleton anchoring proteins (catenins).
  • Main Results:

    • A correlation was observed between decreased E-cadherin expression and poor survival in bladder and prostate cancer patients.
    • Defective E-cadherin function can arise from multiple molecular alterations.
    • Decreased gene transcription is a significant factor contributing to reduced E-cadherin expression in tumors.

    Conclusions:

    • E-cadherin expression is a significant prognostic indicator in bladder and prostate cancers.
    • Targeting E-cadherin transcription regulation presents a potential therapeutic strategy for restoring normal expression and improving patient outcomes.
    • Further large-scale prospective studies are warranted to confirm the clinical usefulness of E-cadherin as a biomarker.